Advertisement

Reactions Weekly

, Volume 1770, Issue 1, pp 155–155 | Cite as

Dolutegravir/lamivudine

Various toxicities: 4 case reports
Case report
  • 24 Downloads

Reference

  1. Hidalgo-Tenorio C, et al. DOLAMA study: Effectiveness, safety and pharmacoeconomic analysis of dual therapy with dolutegravir and lamivudine in virologically suppressed HIV-1 patients. Medicine 98: e16813, No. 32, Aug 2019. Available from: URL: http://doi.org/10.1097/MD.0000000000016813 -Spain

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations